ARCHIVES

DeLap: Seven Years In industry Provided View Of Pressures On Drug Developers

This article is from The Cancer Letter archive.

Vol. 22 No. 31 | August 2, 1996

Download PDF Visit The Full Archive

Related Articles

In Brief: Hendrix To Head Children’s Memorial Institute

June 20, 2003

Herceptin Recommended As Adjuvant For HER2 Positive Early Breast Cancer

May 27, 2005

ACCP Publishes Guidelines Recommending Low-Dose CT

May 31, 2013

DeVita Says He Did Not Agree To Include “Chop-Like” Elements In CCOP RFA But That He Would Consider It

March 19, 1982

Unclear Whether Insurance Will Cover AACR Losses

April 25, 2003

Final Issue of ‘76

December 10, 1976